Translating genetic findings to targeted therapies for children with rare diseases – GT Pharma 2025

GraphTalk Pharma & LifeScience 2025

Project AMIGO is the gateway to data-driven pediatric care. We unite industry and European top-tier (university) pediatric clinics to accelerate genetic diagnosis, targeted therapy, and clinical trials—all within a secure, federated data network.
• Faster Patient Access: Compress the diagnostic timeline so children can benefit from effective treatments sooner.
• Precise Targeting: Pinpoint relevant patient groups for new or existing solutions, enhancing success rates.
• Real-Time Insights: Harness ongoing data on disease progression and therapeutic responses to guide strategic decisions.

AMIGO leverages mixed funding from government, academia, and industry to ensure a sustainable approach that can truly transform pediatric healthcare for the long term.

Speakers:
Nicola Götzenberger – Global Liaison Manager, LMU Klinikum
Daniel Weiss – Computational Scientist, LMU Klinikum

#neo4j #graphdatabase #lifescience #pharma